down arrow

Shandong Keyuan Pharmaceutical Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: CNE1000061V8
CNY
27.95
-7.07 (-20.19%)

Dec 05

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Shandong Keyuan Pharmaceutical Co., Ltd.
Why is Shandong Keyuan Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 1.38% and Operating profit at -25.09% over the last 5 years
  • INTEREST(9M) At CNY 0.05 MM has Grown at inf%
  • OPERATING CASH FLOW(Y) Lowest at CNY -45.46 MM
  • DEBT-EQUITY RATIO (HY) Highest at -19.34 %
2
Below par performance in long term as well as near term
  • Along with generating -21.97% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shandong Keyuan Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Shandong Keyuan Pharmaceutical Co., Ltd.
-100.0%
0.81
46.43%
China Shanghai Composite
15.19%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
1.38%
EBIT Growth (5y)
-25.09%
EBIT to Interest (avg)
58.58
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.33
Tax Ratio
6.19%
Dividend Payout Ratio
35.83%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.47%
ROE (avg)
5.63%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
0.62
EV to EBIT
12.79
EV to EBITDA
6.92
EV to Capital Employed
0.53
EV to Sales
1.32
PEG Ratio
1.68
Dividend Yield
0.60%
ROCE (Latest)
4.16%
ROE (Latest)
4.81%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -55.53% (YoY

NET PROFIT(9M)

Higher at CNY 63.36 MM

NET SALES(Q)

At CNY 115.46 MM has Grown at 31.32%

OPERATING PROFIT MARGIN(Q)

Highest at 23.42 %

-12What is not working for the Company
INTEREST(9M)

At CNY 0.05 MM has Grown at inf%

OPERATING CASH FLOW(Y)

Lowest at CNY -45.46 MM

DEBT-EQUITY RATIO (HY)

Highest at -19.34 %

Here's what is working for Shandong Keyuan Pharmaceutical Co., Ltd.
Net Sales
At CNY 115.46 MM has Grown at 31.32%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit Margin
Highest at 23.42 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Net Profit
Higher at CNY 63.36 MM
than preceding 12 month period ended Jun 2025
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

Net Profit (CNY MM)

Raw Material Cost
Fallen by -55.53% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
At CNY 12.84 MM has Grown at inf%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (CNY MM)

Here's what is not working for Shandong Keyuan Pharmaceutical Co., Ltd.
Interest
At CNY 0.05 MM has Grown at inf%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow
Lowest at CNY -45.46 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Debt-Equity Ratio
Highest at -19.34 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."